Greenland Mines (GRML) risk factors

57 risks, 3 dropped, 3 reworded since the prior year. Greenland Mines faces ongoing Nasdaq delisting risks due to minimum bid price compliance issues.

60 risks. Greenland Mines faces ongoing financial losses and needs substantial funding to develop its biosimilar and gene therapy pipelines. The business is heavily dependent on unproven technologies, strict regulatory approvals, and third-party manufacturing and licensing partners.